IL6 and hepatocellular carcinoma: Together with their findings that the expression levels of IL-6 in human HCC tumors were highly associated with the prognosis of HCC patients, they highlighted the possibility of improving HCC treatment by targeting YAP-IL-6-mediated TAM recruitment [107].